SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
xfwang
Lv6
2330 积分
2021-12-27 加入
最近求助
最近应助
互助留言
Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study
11天前
已完结
Potential predictors for survival in hepatocellular carcinoma patients treated with immune checkpoint inhibitors: A meta-analysis
1个月前
已完结
Prospective Randomized Controlled Phase III Trial Comparing the Efficacy of Sorafenib versus Sorafenib in Combination with Low-Dose Cisplatin/Fluorouracil Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma
1个月前
已完结
Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma
1个月前
已完结
Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer
1个月前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
2个月前
已完结
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
2个月前
已完结
Surrogate and modified endpoints for immunotherapy in advanced hepatocellular carcinoma
2个月前
已完结
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
2个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
4个月前
已完结
没有进行任何应助
感谢,点赞
1个月前
感谢,点赞
1个月前
感谢,点赞
1个月前
感谢,点赞,速度真快
2个月前
感谢,点赞
4个月前
感谢,点赞
6个月前
感谢,点赞,速度真快,帮大忙了,么么哒
7个月前
感谢
1年前
麻烦提供appendix p 3 (protocol)的附件文件,谢谢!
1年前
不需要【积分已退回】
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论